“It has been the contention of DEA and the Dept. of Justice for several years that companies involved in shipping and delivering controlled substances must ensure that both providers and shipment recipients are authorized (licensed) to make or receive these shipments. In “normal” distribution, a licensed manufacturer of such drugs ships them to a licensed […]
Tag: designated representative
Florida Certified Designated Representative (CDR) Exam Prep
California Designated Representative Training Courses (approved by the California State Board of Pharmacy) – Available around-the-clock 24 x 7 Florida Certified Designated Representative CDR Exam Prep Course The Designated Representative Institute Updated April 10, 2018 The Florida DBPR website has been redesigned. Here’s how to get the most current version of the Florida CDR Candidate Information […]
FDA Law Blog: And So It Begins: FDA Issues First DSCSA Guidance
The FDA just published: Guidance for Industry – Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification (PDF) William Koustas (FDA Law Blog) writes, “The DSCSA tasked FDA with addressing three issues in this guidance: (1) identifying scenarios that could increase the risk of suspect product entering the supply chain; (2) recommending […]
Your Florida CDR just quit. What do you do?
“My company is a prescription drug wholesale distributor (in-state or out-of-state). Our Certified Designated Representative (CDR) just quit. What do we do? Notify the department within 10 business days from the CDR’s separation. Your company may continue to distribute prescription drugs in or into Florida during that 10-business day-period. After that period expires, however, your company must either (a) […]
The Differences Between The DSCSA, FDA Rules and Guidance – RxTrace
How To Approach, Read, and Interpret the DSCSA Another great educational snippet from Dirk Rodgers (RxTrace). Follow the link below to read his full article. “So let’s apply that to the exchange of Transaction Information TI, Transaction History TI, and Transaction Statements TS that all U.S. pharma supply chain trading partners must do beginning on […]
FDA DSCSA Workshop – Meeting Materials
Follow the link below to the FDA webpage of all related meeting materials and notices: “[This FDA public workshop, May 8-9, 2014, was] intended to gather information, current practices, research and ideas on the standards for the exchange of transaction information, transaction history and transaction statements, in paper or electronic format, for each transfer of […]